Gelonghui December 7 | Shanghai Yizhong, Zhendong Pharmaceutical, Haichuang Pharmaceutical, and Zejing Pharmaceutical rose more than 5%. According to the news, Hong Kong stock innovative drug leader Pharmacoming Biotech recently announced that according to the repurchase authorization, the company was allowed to repurchase up to 425 million shares from the Hong Kong Stock Exchange, accounting for 10% of the total number of shares issued on the day of the Annual General Meeting of Shareholders.
A股创新药概念股探底回升 南京新百直线拉升涨停
A-share innovative drug concept stocks bottomed out and rebounded, Nanjing Xinbai pulled up and stopped rising
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.